Azenta, Inc. provides life sciences solutions focused on cold-chain sample management, automated storage, consumables, informatics, repository services and multiomics offerings. Its updates commonly cover the Sample Management Solutions and Multiomics businesses, including genomic services, gene synthesis execution, sample storage, high-throughput processing and branded products such as GENEWIZ, FluidX, Ziath, 4titude, Limfinity, Freezer Pro and Barkey.
Azenta news also includes quarterly operating results, guidance updates, long-range planning, governance and leadership changes, customer and research partnerships, and acquisition activity. The completed acquisition of UK Biocentre expanded the company’s sample management, sample storage and processing capabilities in the United Kingdom and added a European operational hub for its Sample Repository Services business.
Summary not available.
Summary not available.
Summary not available.
Summary not available.
Summary not available.
Azenta, Inc. (Nasdaq: AZTA) announced its participation in the 22nd Annual Needham Virtual Healthcare Conference scheduled for April 18, 2023, with a presentation starting at 9:30 am ET. Investors can access the live webcast via Azenta's investor relations website, and a replay will be available after the event.
Azenta is a leading provider of life sciences solutions, focusing on enhancing drug development and clinical research. The company offers a comprehensive range of cold-chain sample management solutions and genomic services for pharmaceutical, biotech, and healthcare institutions globally. Headquartered in Burlington, MA, Azenta operates in North America, Europe, and Asia. For further details, visit www.azenta.com.
Azenta, Inc. (Nasdaq: AZTA) will participate in the Virtual KeyBanc Capital Markets Life Sciences & MedTech Investor Forum on March 21, 2023, with a presentation starting at 4:30 pm ET. Investors can access the live webcast on the Azenta investor relations website and a replay will be available after the event. Azenta is a global leader in life sciences solutions, offering cold-chain sample management and genomic services for drug development and clinical research. Headquartered in Burlington, MA, the company operates across North America, Europe, and Asia.
Summary not available.
Azenta, Inc. (Nasdaq: AZTA) announced its participation in two investor conferences in March 2023. The first event is the Cowen 43rd Annual Health Care Conference in Boston, MA, on March 7th, featuring a presentation at 12:50 pm ET. The second is the Barclays Global Healthcare Conference in Miami, FL, on March 15th, with a presentation starting at 3:35 pm ET. Investors can access the live webcasts via the Azenta investor relations website, with replays available thereafter. Azenta provides life sciences solutions, focusing on cold-chain sample management and genomic services for global healthcare institutions.
Azenta (NASDAQ: AZTA) has launched the Cryo Store Pico™, an automated cryogenic storage system aimed at high-value biological samples across various stages of life sciences. The Pico enhances sample integrity and regulatory compliance, offering features specifically tailored for cell and gene therapy developers. It facilitates controlled access and traceability while maintaining a compact design for clinical use. The product is now available for order and will be showcased at the SLAS 2023 International Conference in San Diego, CA. Azenta aims to speed up breakthroughs in life sciences with its innovative cryogenic solutions.